Project Grant HT94252410668
Award Date
9/15/24
Completion Date
9/14/27
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $975,210.00 to New York University (NYU) School of Medicine to conduct research on the "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure". The award period runs from September 15, 2024 to September 14, 2027. Through this funding, NYU School of Medicine will carry out innovative biomedical research investigating the genetic and...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $325,947 Project Grant to New York University (NYU) School of Medicine on September 15, 2024. The grant supports a 3-year research project titled "Genomic and Molecular Imprints of Carcinogenic Benzene Exposure." This funding enables NYU's research team to investigate the genomic and molecular impacts of benzene exposure, with the goal of advancing scientific...
New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...
New York University School of Medicine was awarded a $911,777 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420).
The grant will fund research into Mitochondrial Dynamics as a Therapy Target in Myelodysplastic Syndromes. Through September 2025, NYU School of Medicine researchers will investigate medical solutions for blood cancers like MDS by exploring mitochondrial functions and their potential...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $787,890 project grant to The Research Foundation For The State University Of New York (Stony Brook University) to conduct a 3-year study on "MORTALITY RISK FROM EXPOSURE TO BERYLLIUM: EXPOSURE ASSESSMENT AND CO-MORBIDITIES". This grant supports research efforts to investigate the mortality risks associated with beryllium exposure, including assessing exposure levels and...
This federal Project Grant award from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program provides $586,660 to the Van Andel Research Institute (VAI) to investigate the molecular mechanisms by which paternal benzene exposure leads to metabolic disease in offspring.
The research aims to: 1) conduct in-depth metabolic and energy homeostasis phenotyping to identify the physiological consequences of paternal benzene exposure in...
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $254,153 to New York University School of Medicine to conduct research on microplastics and prostate cancer. The award will fund a 2-year project from March 1, 2025 to February 28, 2027. As a leading academic medical center and research institution, New York University School of Medicine has a strong track record of receiving substantial...
This Project Grant award from the National Institute of Environmental Health Sciences (NIEHS), under the Environmental Health (CFDA 93.113) program, provides $294,253 to Physical Sciences Inc. (PSI) to develop a high-sensitivity, real-time benzene detector for environmental field surveys. The key objectives are to engineer a laboratory prototype capable of detecting benzene in parts-per-billion concentrations, establish its performance, and demonstrate operations in outdoor urban...
The Department of the Army Medical Command awarded New York University School of Medicine a $1,186,500 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2024 to understand the transition from nevi to melanoma occurring within the skin epidermis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
This $2,660,756 federal Project Grant award from the Department of Defense's Defense Health Agency supports research on "GENOMIC AND IMMUNOMIC MECHANISMS OF RESISTANCE DURING DARATUMUMAB POST STEM CELL TRANSPLANTATION IN PATIENTS WITH POOR-RISK T CELL LYMPHOBLASTIC LYMPHOMA LEUKEMIA". It is funded under the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research to address health conditions affecting service members and veterans. The...